Heliogen (NYSE:HLGN) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate of $(0.06) by 83.33 percent.
Why BlueJay Diagnostics Stock Is Falling
Bluejay Diagnostics, Inc. (NASDAQ: BJDX) shares are trading lower Thursday after the company announced the pricing of a $3.5 million public offering.